Masimo Gross Profit 2007-2018 | MASI

Masimo annual/quarterly gross profit history and growth rate from 2007 to 2018. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Masimo gross profit for the quarter ending December 31, 2018 was $0.148B, a 6.98% increase year-over-year.
  • Masimo gross profit for the twelve months ending December 31, 2018 was $0.575B, a 10.13% increase year-over-year.
  • Masimo annual gross profit for 2018 was $0.575B, a 10.13% increase from 2017.
  • Masimo annual gross profit for 2017 was $0.522B, a 9.13% increase from 2016.
  • Masimo annual gross profit for 2016 was $0.478B, a 16.67% increase from 2015.
Masimo Annual Gross Profit
(Millions of US $)
2018 $575
2017 $522
2016 $478
2015 $410
2014 $391
2013 $359
2012 $326
2011 $294
2010 $286
2009 $249
2008 $218
2007 $183
2006 $163
2005 $65
Masimo Quarterly Gross Profit
(Millions of US $)
Q4 2018 $148
Q3 2018 $141
Q2 2018 $142
Q1 2018 $144
Q4 2017 $139
Q3 2017 $124
Q2 2017 $127
Q1 2017 $132
Q4 2016 $139
Q3 2016 $110
Q2 2016 $115
Q1 2016 $114
Q4 2015 $102
Q3 2015 $102
Q2 2015 $103
Q1 2015 $103
Q4 2014 $109
Q3 2014 $96
Q2 2014 $93
Q1 2014 $92
Q4 2013 $91
Q3 2013 $87
Q2 2013 $91
Q1 2013 $90
Q4 2012 $87
Q3 2012 $78
Q2 2012 $81
Q1 2012 $79
Q4 2011 $74
Q3 2011 $68
Q2 2011 $75
Q1 2011 $77
Q4 2010 $74
Q3 2010 $72
Q2 2010 $70
Q1 2010 $70
Q4 2009 $66
Q3 2009 $62
Q2 2009 $60
Q1 2009 $61
Q4 2008 $59
Q3 2008 $56
Q2 2008 $53
Q1 2008 $50
Q4 2007 $49
Q3 2007 $46
Q2 2007 $46
Q1 2007 $42
Q3 2006 $43
Q2 2006 $41
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.109B $0.858B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $105.261B 23.72
Intuitive Surgical (ISRG) United States $64.748B 60.48
Edwards Lifesciences (EW) United States $39.266B 40.21
Fresenius Medical Care AG KGaA (FMS) Germany $23.664B 16.20
IDEXX Laboratories (IDXX) United States $18.873B 51.39
ABIOMED (ABMD) United States $14.572B 96.19
Teleflex (TFX) United States $13.884B 30.44
Hologic (HOLX) United States $13.648B 20.64
Varian Medical Systems (VAR) United States $12.581B 31.43
DexCom (DXCM) United States $11.613B 444.93
STERIS (STE) United Kingdom $10.406B 26.74
Penumbra (PEN) United States $5.474B 309.73
Integra LifeSciences Holdings (IART) United States $4.712B 22.85
Globus Medical (GMED) United States $4.682B 28.42
LivaNova (LIVN) United Kingdom $4.628B 28.53
Wright Medical Group (WMGI) Netherlands $3.980B 0.00
Tandem Diabetes Care (TNDM) United States $3.969B 0.00
Glaukos (GKOS) United States $2.896B 0.00
Cantel Medical (CMD) United States $2.757B 27.41
Integer Holdings (ITGR) United States $2.736B 22.32
Inogen (INGN) United States $1.966B 39.18
AVANOS MEDICAL, INC (AVNS) United States $1.941B 21.08
Nevro (NVRO) United States $1.885B 0.00
OPKO Health (OPK) United States $1.557B 0.00
Pacific Biosciences Of California (PACB) United States $1.102B 0.00
Accelerate Diagnostics (AXDX) United States $1.083B 0.00
Luminex (LMNX) United States $1.067B 48.73
ORTHOFIX MEDICAL INC (OFIX) United States $1.059B 28.78
Tactile Systems Technology (TCMD) United States $1.045B 198.46
CryoLife (CRY) United States $1.043B 112.44
Veracyte (VCYT) United States $1.006B 0.00
Intersect ENT (XENT) United States $0.968B 0.00
Fluidigm (FLDM) United States $0.938B 0.00
Mesa Laboratories (MLAB) United States $0.875B 35.79
Natus Medical (BABY) United States $0.851B 17.75
AngioDynamics (ANGO) United States $0.811B 26.30
ViewRay (VRAY) United States $0.808B 0.00
AxoGen (AXGN) United States $0.795B 0.00
OrthoPediatrics (KIDS) United States $0.654B 0.00
Quotient (QTNT) Switzerland $0.556B 0.00
TransEnterix (TRXC) United States $0.482B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.462B 48.72
Si-Bone (SIBN) United States $0.440B 0.00
Accuray (ARAY) United States $0.414B 0.00
GenMark Diagnostics (GNMK) United States $0.412B 0.00
Corindus Vascular Robotics (CVRS) United States $0.390B 0.00
Pulse Biosciences (PLSE) United States $0.372B 0.00
RTI Surgical (RTIX) United States $0.357B 52.09
IRadimed (IRMD) United States $0.304B 64.19
SeaSpine Holdings (SPNE) United States $0.282B 0.00
Sientra (SIEN) United States $0.276B 0.00
Neuronetics (STIM) United States $0.262B 0.00
Nuvectra (NVTR) United States $0.206B 0.00
CRH Medical (CRHM) Canada $0.188B 43.67
ConforMIS (CFMS) United States $0.162B 0.00
Helius Medical Technologies (HSDT) United States $0.159B 0.00
Ekso Bionics Holdings (EKSO) United States $0.153B 0.00
T2 Biosystems (TTOO) United States $0.129B 0.00
Biosig Technologies (BSGM) United States $0.121B 0.00
Sensus Healthcare (SRTS) United States $0.121B 0.00
SOLITON INC (SOLY) $0.114B 0.00
Alphatec Holdings (ATEC) United States $0.114B 0.00
Second Sight Medical Products (EYES) United States $0.106B 0.00
Vermillion (VRML) United States $0.103B 0.00
Apollo Endosurgery (APEN) United States $0.088B 0.00
EDAP TMS (EDAP) France $0.085B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.073B 0.00
Titan Medical (TMDI) Canada $0.065B 0.00
Ra Medical Systems (RMED) United States $0.050B 0.00
Electromed (ELMD) United States $0.045B 23.17
Viveve Medical (VIVE) United States $0.044B 0.00
Xtant Medical Holdings (XTNT) United States $0.040B 0.00
Avinger (AVGR) United States $0.037B 0.00
OBALON THERPTCS (OBLN) United States $0.037B 0.00
Microbot Medical (MBOT) United States $0.034B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.028B 0.00
PAVmed (PAVM) United States $0.028B 0.00
DarioHealth (DRIO) Israel $0.027B 0.00
Restoration Robotics (HAIR) United States $0.027B 0.00
Lianluo Smart (LLIT) China $0.026B 0.00
ENDRA Life Sciences (NDRA) United States $0.021B 0.00
Atossa Genetics (ATOS) United States $0.021B 0.00
Bioanalytical Systems (BASI) United States $0.021B 66.67
Dynatronics (DYNT) United States $0.017B 0.00
American Shared Hospital Services (AMS) United States $0.016B 12.17
ReWalk Robotics (RWLK) Israel $0.016B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Presbia (LENS) Ireland $0.012B 0.00
Neovasc (NVCN) Canada $0.012B 0.00
Micron Solutions (MICR) United States $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00